Limit search to items available for checkout
Save Marked Records Save All On Page
Subjects (1-22 of 22)
Drugs -- United States -- Costs.
1
2018
E-REPORT
The administration's FDA reforms and reduced biopharmaceutical drug prices
Council of Economic Advisers (U.S.), author.
[Washington, D.C.] : Executive Office of the President of the United States, Council of Economic Advisers, 2018.

Copies / Volumes

LOCATION CALL # STATUS
 Internet  Electronic Report    AVAILABLE
2
2009
E-REPORT
Audit of consolidated mail outpatient pharmacy contract management
United States. Department of Veterans Affairs. Office of Inspector General.
Washington, DC : U.S. Dept. of Veterans Affairs, Office of Inspector General, [2009]

Copies / Volumes

LOCATION CALL # STATUS
 Internet  Electronic Report    AVAILABLE
3
2010
E-REPORT
End stage renal disease drugs : facility acquisition costs and future Medicare payment concerns.
United States. Department of Health and Human Services. Office of Inspector General, author.
Washington, D.C. : Department of Health and Human Services, Office of Inspector General, 2010.

Copies / Volumes

LOCATION CALL # STATUS
 Internet  Electronic Report    AVAILABLE
4
2019
E-REPORT
From joint pain to pocket pain : cost and competition among rheumatoid arthritis therapies : hearin
United States. Congress. Senate. Special Committee on Aging, author.
Washington : U.S. Government Publishing Office, 2019.

Copies / Volumes

LOCATION CALL # STATUS
 Internet  Electronic Report    AVAILABLE
5
2009
BOOK
Hearing on beneficiary protections in Medicare Part D : hearing before the Subcommittee on Health of
United States. Congress. House. Committee on Ways and Means. Subcommittee on Health.
Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2009.

Copies / Volumes

LOCATION CALL # STATUS
 GovDocs Federal  Y 4.W 36:110-50    AVAILABLE
6
2009
E-REPORT
Hearing on beneficiary protections in Medicare Part D hearing before the Subcommittee on Health of t
United States. Congress. House. Committee on Ways and Means. Subcommittee on Health.
Washington : U.S. G.P.O., 2009.

Copies / Volumes

LOCATION CALL # STATUS
 Internet  Electronic Report    AVAILABLE
7
1993
MICROFORM
Medicaid changes in drug prices paid by HMOs and hospitals since enactment of rebate provisions : re
United States. General Accounting Office.
Washington, D.C. : The Office ; Gaithersburg, MD (P.O. Box 6015, Gaithersburg 20884-6015) : The Office [distributor, 1993]

Copies / Volumes

LOCATION CALL # STATUS
 GovDocs Federal/Fiche  GA 1.13:HRD-93-43    AVAILABLE
8
1991
MICROFORM
Medicaid, changes in drug prices paid by VA and DOD since enactment of rebate provisions report to c
United States. General Accounting Office.
Washington, D.C. : The Office ; Gaithersburg, MD (P.O. Box 6015, Gaithersburg 20877) : The Office [distributor, 1991]

Copies / Volumes

LOCATION CALL # STATUS
 GovDocs Federal/Fiche  GA 1.13:HRD-91-139    AVAILABLE
9
1993
MICROFORM
Medicaid outpatient drug costs and reimbursements for selected pharmacies in Illinois and Maryland :
United States. General Accounting Office.
Washington, D.C. : The Office ; [Gaithersburg, Md.] (P.O. Box 6015, Gaithersburg 20884-6015) : The Office [distributor, 1993]

Copies / Volumes

LOCATION CALL # STATUS
 GovDocs Federal/Fiche  GA 1.13:HRD-93-55 FS    INVENTORY
10
2004
E-REPORT
Medicaid's reimbursements to pharmacies for prescription drugs
Anderson, Todd.
[Washington, D.C.] : Congress of the U.S., Congressional Budget Office, [2004]

Copies / Volumes

LOCATION CALL # STATUS
 Internet  Electronic Report    AVAILABLE
11
2012
E-REPORT
Medicare high-expenditure Part B drugs
Cosgrove, James C.
Washington, DC : U.S. Govt. Accountability Office, [2012]

Copies / Volumes

LOCATION CALL # STATUS
 Internet  Electronic Report    AVAILABLE
12
2012
E-REPORT
Medicare payments for drugs used to treat wet age related macular degeneration.
United States. Department of Health and Human Services. Office of Inspector General, author.
[Washington, D.C.] : Department of Health and Human Services, Office of Inspector General, 2012.

Copies / Volumes

LOCATION CALL # STATUS
 Internet  Electronic Report    AVAILABLE
13
2004
E-REPORT
Medicare reimbursement for existing end stage renal disease drugs.
United States. Department of Health and Human Services. Office of Inspector General, author.
[Washington, D.C.] : Department of Health and Human Services, Office of Inspector General, 2004.

Copies / Volumes

LOCATION CALL # STATUS
 Internet  Electronic Report    AVAILABLE
14
2007
E-REPORT
Medicare reimbursement for existing end stage renal disease drugs : third quarter 2006.
United States. Department of Health and Human Services. Office of Inspector General, author.
[Washington, D.C.] : Department of Health and Human Services, Office of Inspector General, 2007.

Copies / Volumes

LOCATION CALL # STATUS
 Internet  Electronic Report    AVAILABLE
15
2006
E-REPORT
Medicare reimbursement for new end stage renal disease drugs.
United States. Department of Health and Human Services. Office of Inspector General, author.
[Washington, D.C.] : Department of Health and Human Services, Office of Inspector General, 2006.

Copies / Volumes

LOCATION CALL # STATUS
 Internet  Electronic Report    AVAILABLE
16
2000
E-REPORT
Medicare reimbursement of end stage renal disease drugs.
United States. Department of Health and Human Services. Office of Inspector General, author.
[Washington, D.C.] : Department of Health and Human Services, Office of Inspector General, 2000.

Copies / Volumes

LOCATION CALL # STATUS
 Internet  Electronic Report    AVAILABLE
17
2019
BOOK
Orange Book Transparency Act of 2019 : report (to accompany H.R. 1503) (including cost estimate of t
United States. Congress. House. Committee on Energy and Commerce, author.
[Washington, D.C.] : [U.S. Government Publishing Office], [2019]

Copies / Volumes

LOCATION CALL # STATUS
 GovDocs Federal  Y 1.1/8:116-47    LIB USE ONLY
18
2019
E-REPORT
Orange Book Transparency Act of 2019 : report (to accompany H.R. 1503) (including cost estimate of t
United States. Congress. House. Committee on Energy and Commerce, author.
[Washington, D.C.] : [U.S. Government Publishing Office], [2019]

Copies / Volumes

LOCATION CALL # STATUS
 Internet  Electronic Report    AVAILABLE
19
2018
E-REPORT
Prescription drug affordability and innovation : addressing challenges in today's market : hearing
United States. Congress. Senate. Committee on Finance, author.
Washington : U.S. Government Publishing Office, 2018.

Copies / Volumes

LOCATION CALL # STATUS
 Internet  Electronic Report    AVAILABLE
20
2020
BOOK
Prescription drug affordability and innovation : addressing challenges in today's market : hearing
United States. Congress. Senate. Committee on Finance, author.
Washington : U.S. Government Publishing Office, 2020.

Copies / Volumes

LOCATION CALL # STATUS
 GovDocs Federal  Y 4.F 49:S.HRG.115-727    AVAILABLE
21
2007
E-REPORT
Tracking beneficiaries' true out-of-pocket costs for the Part D prescription drug benefit.
United States. Department of Health and Human Services. Office of Inspector General, author.
[Washington, D.C.] : Department of Health and Human Services, Office of Inspector General, 2007.

Copies / Volumes

LOCATION CALL # STATUS
 Internet  Electronic Report    AVAILABLE
22
2014
E-REPORT
Update : Medicare payments for end stage renal disease drugs.
United States. Department of Health and Human Services. Office of Inspector General, author.
Washington, DC : Department of Health and Human Services, Office of Inspector General, 2014.

Copies / Volumes

LOCATION CALL # STATUS
 Internet  Electronic Report    AVAILABLE
Save Marked Records Save All On Page
Locate in results